What's new

Orphan designation: Ganaxolone Treatment of CDKL5 deficiency disorder, 13/11/2019 Positive

Orphan designation: Ganaxolone Treatment of CDKL5 deficiency disorder, 13/11/2019 Positive

Jun 5, 2025 - 15:00
 0
Orphan designation: Ganaxolone Treatment of CDKL5 deficiency disorder, 13/11/2019 Positive
Orphan designation: Ganaxolone Treatment of CDKL5 deficiency disorder, 13/11/2019 Positive
Read More

Tags:

Previous Article

Orphan designation: defibrotide Prevention of graft-versus-host disease, 13/11/2...

Next Article

Orphan designation: single guide RNA targeting the human TTR gene, Ziclumeran Tr...

Related Posts

Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0

ICH M12 on drug interaction studies - Scientific guideline

ICH M12 on drug interaction studies - Scientific guideline

May 23, 2025  0

Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Status: Opinion

Human medicines European public assessment report (EPAR...

May 23, 2025  0